Anti-CD81 [1s337] monoclonal antibody
RECENTLY UPDATED
RECENTLY UPDATED
Invented at University Of Birmingham
- Datasheet
- References (1)
- Inventor Info
Info
| Catalogue Number | 154256 |
|
Applications
RECENTLY UPDATED
|
ELISA FACS IF WB |
|
Antigen/Gene or Protein Targets
RECENTLY UPDATED |
CD81 and its second extracellular domain (EC2) |
|
Synonyms
RECENTLY UPDATED |
26 kDa cell surface protein TAPA-1,Target of the antiproliferative antibody 1, Tetraspanin-28 |
|
Reactivity
RECENTLY UPDATED
|
Human |
|
Relevance
RECENTLY UPDATED |
CD81 is co-opted during the life cycle of diverse human pathogens: it is involved in hepatitis C virus (HCV) and Plasmodium sporozoite invasion of hepatocytes, and also contributes to the assembly and budding of human immunodeficiency virus and influenza A virus. Developed as a part of panel of murine monoclonal antibodies against full-length CD81 to further examine and assessed their ability to inhibit or neutralize HCV infection. |
|
Host
RECENTLY UPDATED
|
Mouse |
|
Immunogen
RECENTLY UPDATED |
Recombinant human CD81 |
|
Immunogen UniProt ID
RECENTLY UPDATED |
P60033, CD81_HUMAN |
|
Myeloma Used
RECENTLY UPDATED |
NS0 |
|
Recommended Growing Conditions
RECENTLY UPDATED |
Grown in RPMI 1640 with penicillin (100ug/ml) and 10% FBS (foetal bovine serum). |
|
Strain
RECENTLY UPDATED |
Balb/c |
|
Research Area
RECENTLY UPDATED |
Immunology, Virology |
References: 1 entry
RECENTLY UPDATED
RECENTLY UPDATED
References: 1 entry
RECENTLY UPDATED
RECENTLY UPDATED
